Literature DB >> 27376741

Noncoding RNAs Regulating NF-κB Signaling.

Mengfeng Li1, Hongyu Guan2.   

Abstract

As transcription factors that regulate expression of a variety of genes essential for diverse physiological and pathological processes, nuclear factor kappa B (NF-κB) family molecules play important roles in the development and progression of malignant tumor, and constitutive activation of NF-κB has been evidenced in various types of tumor tissues. Underlying its pathologic role, deregulated expression and/or transactivating activity of NF-κB usually involves multiple layers of molecular mechanisms. Noncoding RNAs, including microRNAs (miRNAs) and long noncoding RNAs (lncRNAs), are known to modulate expression and biological functions of regulatory proteins in a variety of cancer contexts. In this chapter, the regulatory role of miRNAs and lncRNAs in NF-κB signaling in malignant diseases will be discussed.

Entities:  

Keywords:  NF-κB; Noncoding RNA; Therapeutics; Tumorigenesis; lncRNAs; miRNAs

Mesh:

Substances:

Year:  2016        PMID: 27376741     DOI: 10.1007/978-981-10-1498-7_12

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  3 in total

Review 1.  Macrophage Long Non-Coding RNAs in Pathogenesis of Cardiovascular Disease.

Authors:  Marcin Wysoczynski; Jae Kim; Joseph B Moore; Shizuka Uchida
Journal:  Noncoding RNA       Date:  2020-07-11

Review 2.  Cascades between miRNAs, lncRNAs and the NF-κB signaling pathway in gastric cancer (Review).

Authors:  Risheng Chen; Mingxiu Yang; Weiguo Huang; Baiyun Wang
Journal:  Exp Ther Med       Date:  2021-05-17       Impact factor: 2.447

3.  Long Non-coding RNA HIX003209 Promotes Inflammation by Sponging miR-6089 via TLR4/NF-κB Signaling Pathway in Rheumatoid Arthritis.

Authors:  Shushan Yan; Pingping Wang; Jinghua Wang; Jinghan Yang; Hongying Lu; Chengwen Jin; Min Cheng; Donghua Xu
Journal:  Front Immunol       Date:  2019-09-18       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.